Elevated plasma or serum lipoprotein(a) (Lp(a)) levels have been associated with premature coronary heart disease (CHD). Lp(a) levels can be assessed quantitatively by electrophoresis and quantitatively by immunoassays determining either total Lp(a) mass, apo(a) mass on Lp(a) protein mass, or by pre
Lipoproteins and coronary heart disease
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 38 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0009-3084
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Small, dense lowβdensity lipoprotein (sdLDL) has been accepted as an emerging cardiovascular risk factor, and there has been an increasing interest in analytical methods for sdLDL profiling for diagnosis. Serum sdLDL may be measured by different laboratory techniques, but all these meth
Robust methods were employed, using data from a single large pedigree, to screen serum apolipoprotein A1 and B levels, serum lipoprotein cholesterol levels, and ratios of serum lipoprotein cholesterol fractions to apolipoprotein A1 and B levels for genetic linkage to 31 polymorphic markers. Segregat
Based on the results of the Prospective Cardiovascular Miinster Study (PROCAM-Trial), new possibilities are shown which permit the recognition of a coronary risk or the prediction of the likelihood of amyocardial infarction. Practical problems in the classification oflipid metabolismdisordersare dis
Hostility, depression, and anxiety have been associated with coronary heart disease (CHD), but the role of emotional distress in the development of CHD is still a controversial issue. Evidence shows, however, that emotional distress plays a key role in the progression of CHD: (i) emotional distress